Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder
Amber S E van Oirsouw(University Medical Center Utrecht), June-Anne Gold(Loma Linda University), Øystein L. Holla(Telemark Hospital), Subhadra Ramanathan(Loma Linda University), Heather Fisher(The University of Texas Southwestern Medical Center), Charlotte von der Lippe(Telemark Hospital), Kelly Bontempo(Advocate Children's Hospital), Kevin E. Glinton(Baylor College of Medicine), Abdulrazak Alali(University of the Virgin Islands), Kara Vitalone(Akron Children's Hospital), Meena Balasubramanian(Sheffield Children's NHS Foundation Trust), Peter Miny(University Hospital of Basel), Klaas Koop(University Medical Center Utrecht), Markéta Vlčková(Northwestern University), Jan Prchal(University of Chemistry and Technology, Prague), John Pappas(New York University), Stephanie Riley(Kennedy Krieger Institute), Kristian Tveten(Telemark Hospital), Deanna Alexis Carere(GenVec), Roberta Sierra(Baylor College of Medicine), Marijn F. Stokman(Inserm), Brad Angle(Advocate Children's Hospital), Gregory Costain(University of Toronto), Jill A. Rosenfeld(Baylor College of Medicine), Rachel Rabin(New York University), Bertrand Isidor(Centre National de la Recherche Scientifique), Isabel Filges(University Children’s Hospital Basel), Pascal Joset(University of Zurich), Albertien M. van Eerde(Hospital Reina Sofía de Murcia), Miroslava Hančárová(Charles University), Šárka Bendová(Charles University), Michael Spiller(Sheffield Children's NHS Foundation Trust), Joann Bodurtha(Johns Hopkins University), Lisa Dyer, Darina Prchalová(Charles University), Angela E. Scheuerle, Renée Perrier(Alberta Children's Hospital), Weimin Bi(Zhejiang A & F University), Kristin G. Monaghan, Nicola Longo(Center for Human Genetics), Yanmin Chen(GenVec), Benjamin Cogné(Centre National de la Recherche Scientifique), David A. Staffenberg(Memorial Sloan Kettering Cancer Center), Mahim Jain(Kennedy Krieger Institute), Emma A M Te Bogt(University Medical Center Utrecht), Pavla Nedbalova(University of South Bohemia in České Budějovice), Marianne Jortveit(Sørlandet Sykehus), Weiyi Mu(Johns Hopkins University), Samuel M Bradbrook(Alberta Children's Hospital), Blake Vuocolo(Baylor College of Medicine)
Cited by 2
Related Papers
Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
|New England Journal of Medicine|2016|774
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
|The American Journal of Human Genetics|2017|456
Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
|Nature Genetics|2012|244